• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期采用 ALPPS 治疗的中心术后并发症和死亡率的差异。

Variation in complications and mortality following ALPPS at early-adopting centers.

机构信息

Department of Surgery, Western University, Ontario, Canada; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Department of Surgery and Transplantation, University Hospital Zurich, Switzerland.

出版信息

HPB (Oxford). 2021 Jan;23(1):46-55. doi: 10.1016/j.hpb.2020.04.009. Epub 2020 May 23.

DOI:10.1016/j.hpb.2020.04.009
PMID:32456975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7680722/
Abstract

BACKGROUND

Various, often conflicting, estimates for post-operative morbidity and mortality following ALPPS have been reported in the literature, suggesting that considerable center-level variation exists. Some of this variation may be related to center volume and experience.

METHODS

Using data from seventeen centers who were early adopters of the ALPPS technique, we estimated the variation, by center, in standardized 90-day mortality and comprehensive complication index (CCI) for patients treated between 2012 and 2018.

RESULTS

We estimated that center-specific 90-day mortality following treatment with ALPPS varied from 4.2% (95% CI: 0.8, 9.9) to 29.1% (95% CI: 13.9, 50.9), and that center-specific CCI following treatment with ALPPS varied from 17.0 (95% CI: 7.5, 26.5) to 49.8 (95% CI: 38.1, 61.8). Declines in estimated 90-day mortality and CCI were observed over time, and almost all individual centers followed this trend. Patients treated at centers with a higher number of ALPPS cases performed over the prior year had a lower risk of post-operative mortality.

CONCLUSION

Despite considerable center-level variation in ALPPS outcomes, perioperative outcomes following ALPPS have improved over time and treatment at higher volume centers results in a lower risk of 90-day mortality. Morbidity and mortality remain concerningly high at some centers.

摘要

背景

文献中报道了各种(常常相互冲突的)ALPPS 术后发病率和死亡率的估计值,这表明存在相当大的中心间差异。这种差异的部分原因可能与中心的数量和经验有关。

方法

我们使用了 17 个早期采用 ALPPS 技术的中心的数据,估计了 2012 年至 2018 年期间接受治疗的患者在中心层面上标准化 90 天死亡率和综合并发症指数(CCI)的差异。

结果

我们估计,采用 ALPPS 治疗后,中心特异性 90 天死亡率从 4.2%(95%CI:0.8,9.9)到 29.1%(95%CI:13.9,50.9)不等,采用 ALPPS 治疗后中心特异性 CCI 从 17.0(95%CI:7.5,26.5)到 49.8(95%CI:38.1,61.8)不等。随着时间的推移,估计的 90 天死亡率和 CCI 呈下降趋势,几乎所有的中心都遵循这一趋势。在过去一年中接受 ALPPS 例数较多的中心治疗的患者,术后死亡率较低。

结论

尽管 ALPPS 结果存在相当大的中心间差异,但 ALPPS 术后的围手术期结果随着时间的推移有所改善,在高容量中心治疗可降低 90 天死亡率的风险。在一些中心,发病率和死亡率仍然令人担忧地高。

相似文献

1
Variation in complications and mortality following ALPPS at early-adopting centers.早期采用 ALPPS 治疗的中心术后并发症和死亡率的差异。
HPB (Oxford). 2021 Jan;23(1):46-55. doi: 10.1016/j.hpb.2020.04.009. Epub 2020 May 23.
2
Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity.ALPPS 中的风险调整与早期死亡率和发病率的显著降低有关。
Ann Surg. 2017 Nov;266(5):779-786. doi: 10.1097/SLA.0000000000002446.
3
Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.不可切除的结直肠癌肝转移患者行联合肝脏分隔和门静脉结扎的分期肝切除术(ALPPS)与两阶段肝切除术(TSH)的手术结果及肿瘤学结局:一项系统评价和荟萃分析
World J Surg. 2018 Mar;42(3):806-815. doi: 10.1007/s00268-017-4181-6.
4
Complete or partial split in associating liver partition and portal vein ligation for staged hepatectomy: A systematic review and meta-analysis.联合肝脏离断和门静脉结扎的分阶段肝切除术中完全或部分劈离:系统评价和荟萃分析。
World J Gastroenterol. 2019 Oct 21;25(39):6016-6024. doi: 10.3748/wjg.v25.i39.6016.
5
Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry.意大利 ALPPS 微创手术技术的演变和手术结果:10 年来国家前瞻性登记处的全面趋势分析。
Surg Endosc. 2023 Jul;37(7):5285-5294. doi: 10.1007/s00464-023-09937-4. Epub 2023 Mar 28.
6
Associating liver partition and portal vein ligation for staged hepatectomy: the current role and development.联合肝脏分隔和门静脉结扎的分期肝切除术:当前作用与进展
Hepatobiliary Pancreat Dis Int. 2017 Feb;16(1):17-26. doi: 10.1016/s1499-3872(16)60174-1.
7
Chance and challenge of associating liver partition and portal vein ligation for staged hepatectomy.联合肝脏离断和门静脉结扎的分阶段肝切除术的机遇和挑战。
Hepatobiliary Pancreat Dis Int. 2019 Jun;18(3):214-222. doi: 10.1016/j.hbpd.2019.04.006. Epub 2019 Apr 24.
8
Defining Benchmark Outcomes for ALPPS.定义 ALPPS 的基准结果。
Ann Surg. 2019 Nov;270(5):835-841. doi: 10.1097/SLA.0000000000003539.
9
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management.联合肝脏分隔和门静脉结扎的分期肝切除术(ALPPS):分期过程对病死率的影响及管理意义
Eur J Surg Oncol. 2015 May;41(5):674-82. doi: 10.1016/j.ejso.2015.01.004. Epub 2015 Jan 17.
10
Avoiding postoperative mortality after ALPPS-development of a tumor-specific risk score for colorectal liver metastases.避免 ALPPS 术后死亡率:结直肠肝转移肿瘤特异性风险评分的发展。
HPB (Oxford). 2019 Jul;21(7):898-905. doi: 10.1016/j.hpb.2018.11.010. Epub 2019 Jan 2.

引用本文的文献

1
Augmenting the Future Liver Remnant Prior to Major Hepatectomy: A Review of Options on the Menu.肝大部切除术前增加未来肝残余量:可选方法综述
Ann Surg Oncol. 2025 Jun 8. doi: 10.1245/s10434-025-17607-z.
2
[Multimorbidity in liver surgery].[肝脏手术中的多重疾病]
Chirurgie (Heidelb). 2025 Feb;96(2):102-107. doi: 10.1007/s00104-024-02222-7. Epub 2025 Jan 8.
3
Role of liver augmentation prior to hepatic resection - a survey on standards, procedures, and indications in Germany, Switzerland, and Austria.肝切除术前肝脏增强的作用 - 德国、瑞士和奥地利的标准、程序和适应证调查。

本文引用的文献

1
Stan: A Probabilistic Programming Language.斯坦:一种概率编程语言。
J Stat Softw. 2017;76. doi: 10.18637/jss.v076.i01. Epub 2017 Jan 11.
2
The HPB controversy of the decade: 2007-2017 - Ten years of ALPPS.过去十年的 HPB 争议:2007-2017 - 十年的 ALPPS。
Eur J Surg Oncol. 2018 Oct;44(10):1624-1627. doi: 10.1016/j.ejso.2018.06.005. Epub 2018 Jun 18.
3
Intermediate-term survival and quality of life outcomes in patients with advanced colorectal liver metastases undergoing associating liver partition and portal vein ligation for staged hepatectomy.
Langenbecks Arch Surg. 2024 Jul 27;409(1):228. doi: 10.1007/s00423-024-03418-5.
4
Challenges and Opportunities for Precision Surgery for Colorectal Liver Metastases.结直肠癌肝转移精准手术面临的挑战与机遇
Cancers (Basel). 2024 Jun 28;16(13):2379. doi: 10.3390/cancers16132379.
5
Full robotic versus open ALPPS: a bi-institutional comparison of perioperative outcomes.全机器人与开放 ALPPS:围手术期结局的双机构比较。
Surg Endosc. 2024 Jun;38(6):3448-3454. doi: 10.1007/s00464-024-10804-z. Epub 2024 May 2.
6
Histological and radiological analysis of simultaneous dual hepatic vein embolization for right-sided major hepatectomy.同时双重肝静脉栓塞在右半肝切除术中的组织学和影像学分析。
Surg Today. 2024 Dec;54(12):1453-1460. doi: 10.1007/s00595-024-02859-1. Epub 2024 Apr 30.
7
Optimizing Growth of the Future Liver Remnant and Making In-Situ Liver Transsection Safe-A Standardized Approach to ISLT or ALPPS.优化未来肝脏残存量的生长,确保原位肝切除术安全——一种标准化的原位肝移植或联合肝脏离断和门静脉结扎的二步肝切除术方法。
Curr Oncol. 2023 Mar 13;30(3):3277-3288. doi: 10.3390/curroncol30030249.
8
Parenchyma-Sparing Liver Resection or Regenerative Liver Surgery: Which Way to Go?保留肝实质的肝切除术或肝脏再生手术:该选哪一种?
Medicina (Kaunas). 2022 Oct 10;58(10):1422. doi: 10.3390/medicina58101422.
9
ALPPS and the endless pursuit of hepatic resectability.联合肝脏离断和门静脉结扎的二步肝切除术(ALPPS)与对肝切除可行性的不懈追求
Hepatobiliary Surg Nutr. 2022 Oct;11(5):732-734. doi: 10.21037/hbsn-22-357.
10
Ipsilateral access portal venous embolization (PVE) for preoperative hypertrophy exhibits low complication rates in Clavien-Dindo and CIRSE scales.用于术前肝脏肥大的同侧入路门静脉栓塞术(PVE)在Clavien-Dindo和CIRSE分级中并发症发生率较低。
CVIR Endovasc. 2021 May 17;4(1):41. doi: 10.1186/s42155-021-00227-5.
接受联合肝脏离断和门静脉结扎的分期肝切除术的晚期结直肠癌肝转移患者的中期生存和生活质量结局。
Surgery. 2018 Apr;163(4):691-697. doi: 10.1016/j.surg.2017.09.044. Epub 2017 Dec 6.
4
ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial).ALPPS 相较于传统两阶段肝切除术可提高晚期结直肠癌肝转移患者的可切除性:一项来自斯堪的纳维亚多中心随机对照试验(LIGRO 试验)的结果。
Ann Surg. 2018 May;267(5):833-840. doi: 10.1097/SLA.0000000000002511.
5
Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity.ALPPS 中的风险调整与早期死亡率和发病率的显著降低有关。
Ann Surg. 2017 Nov;266(5):779-786. doi: 10.1097/SLA.0000000000002446.
6
Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.不可切除的结直肠癌肝转移患者行联合肝脏分隔和门静脉结扎的分期肝切除术(ALPPS)与两阶段肝切除术(TSH)的手术结果及肿瘤学结局:一项系统评价和荟萃分析
World J Surg. 2018 Mar;42(3):806-815. doi: 10.1007/s00268-017-4181-6.
7
Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy.关联肝脏分区与门静脉结扎和门静脉阻断的两阶段肝切除术的荟萃分析。
Br J Surg. 2016 Dec;103(13):1768-1782. doi: 10.1002/bjs.10290. Epub 2016 Sep 16.
8
Hospital variation in outcomes following appendectomy in a regional quality improvement program.区域质量改进项目中阑尾切除术后结局的医院差异
Am J Surg. 2016 Nov;212(5):857-862. doi: 10.1016/j.amjsurg.2016.02.011. Epub 2016 May 6.
9
Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results.结直肠癌肝转移患者肝段划分联合门静脉结扎分期肝切除术——中期肿瘤学结果
Eur J Surg Oncol. 2016 Apr;42(4):531-7. doi: 10.1016/j.ejso.2015.12.013. Epub 2016 Jan 21.
10
ALPPS--Where Do We Stand, Where Do We Go?: Eight Recommendations From the First International Expert Meeting.联合肝脏分隔和门静脉结扎的分阶段肝切除术——我们目前的状况与未来走向:首次国际专家会议的八项建议
Ann Surg. 2016 May;263(5):839-41. doi: 10.1097/SLA.0000000000001633.